share_log
Breakings ·  Oct 26 05:52
Sands Capital Life Sciences Pulse Fund II, L.p. Reports 16.3% Passive Stake in Inhibikase Therapeutics, Inc as of Oct 21 - SEC Filing
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment